Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 5
2018 1
2019 7
2020 6
2021 7
2022 6
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders.
Kaegi C, Wuest B, Schreiner J, Steiner UC, Vultaggio A, Matucci A, Crowley C, Boyman O. Kaegi C, et al. Front Immunol. 2019 Sep 6;10:1990. doi: 10.3389/fimmu.2019.01990. eCollection 2019. Front Immunol. 2019. PMID: 31555262 Free PMC article.
Conclusions: Rituximab is both safe and effective for the treatment of acquired angioedema with C1-inhibitor deficiency, ANCA-associated vasculitis, autoimmune hemolytic anemia, Behcet's disease, bullous pemphigoid, Castleman's disease, cryoglobulinemia, Goodpasture's disease, …
Conclusions: Rituximab is both safe and effective for the treatment of acquired angioedema with C1-inhibitor deficiency, ANCA-associated vas …
Immunoglobulin-G4-related skin disease.
Katerji R, Smoller BR. Katerji R, et al. Clin Dermatol. 2021 Mar-Apr;39(2):283-290. doi: 10.1016/j.clindermatol.2020.10.009. Epub 2020 Oct 16. Clin Dermatol. 2021. PMID: 34272023
Recently, there has been increased awareness of cutaneous involvement by IgG4-RD either as an isolated lesion or primary involvement or as a secondary involvement from a systemic disease. Clinically, cutaneous IgG4+-related disease presents as papules, plaque …
Recently, there has been increased awareness of cutaneous involvement by IgG4-RD either as an isolated lesion or primary involvement or as a …
Clinicopathological characteristics of gastric IgG4-related disease: Systematic scoping review.
Sawada H, Czech T, Silangcruz K, Kozai L, Obeidat A, Wien EA, Nishimura MF, Nishikori A, Sato Y, Nishimura Y. Sawada H, et al. J Gastroenterol Hepatol. 2022 Oct;37(10):1865-1872. doi: 10.1111/jgh.15980. Epub 2022 Aug 21. J Gastroenterol Hepatol. 2022. PMID: 35949057 Review.
BACKGROUND AND AIM: Gastric IgG4-related disease (IgG4-RD) can mimic malignancy, submucosal tumors (SMT), and ulcers, leading to over-triage and unnecessary medical interventions such as gastrectomy. The variability in the clinicopathological presentation of …
BACKGROUND AND AIM: Gastric IgG4-related disease (IgG4-RD) can mimic malignancy, submucosal tumors (SMT), and ulcers, l …
Cutaneous manifestations of IgG4-related disease (RD): A systematic review.
Charrow A, Imadojemu S, Stephen S, Ogunleye T, Takeshita J, Lipoff JB. Charrow A, et al. J Am Acad Dermatol. 2016 Jul;75(1):197-202. doi: 10.1016/j.jaad.2016.01.046. Epub 2016 Mar 4. J Am Acad Dermatol. 2016. PMID: 26946983 Review.
BACKGROUND: IgG4-related disease (RD) is a recently described fibroinflammatory condition with both cutaneous and systemic manifestations. ...
BACKGROUND: IgG4-related disease (RD) is a recently described fibroinflammatory condition with both cutaneous and syste …
IgG4-related skin disease may have distinct systemic manifestations: a systematic review.
Bennett AE, Fenske NA, Rodriguez-Waitkus P, Messina JL. Bennett AE, et al. Int J Dermatol. 2016 Nov;55(11):1184-1195. doi: 10.1111/ijd.13369. Int J Dermatol. 2016. PMID: 27419384 Review.
IgG4-related disease (IgG4-RD) is an increasingly prevalent protean multisystem disorder characterized by single or multi-organ infiltration of IgG4-bearing plasma cells. ...Plasmacyte infiltration and storiform fibrosis are prominent in IgG4-related skin dis …
IgG4-related disease (IgG4-RD) is an increasingly prevalent protean multisystem disorder characterized by single or mul …
Therapeutic approach to IgG4-related disease: A systematic review.
Brito-Zerón P, Kostov B, Bosch X, Acar-Denizli N, Ramos-Casals M, Stone JH. Brito-Zerón P, et al. Medicine (Baltimore). 2016 Jun;95(26):e4002. doi: 10.1097/MD.0000000000004002. Medicine (Baltimore). 2016. PMID: 27368010 Free PMC article. Review.
To review the reported evidence on the therapeutic management of IgG4-related disease (IgG4-RD) in clinical practice.A systematic search of the literature was conducted. ...
To review the reported evidence on the therapeutic management of IgG4-related disease (IgG4-RD) in clinical practice.A …
Biomarkers in IgG4-related disease: A systematic review.
Tang J, Cai S, Ye C, Dong L. Tang J, et al. Semin Arthritis Rheum. 2020 Apr;50(2):354-359. doi: 10.1016/j.semarthrit.2019.06.018. Epub 2019 Jun 28. Semin Arthritis Rheum. 2020. PMID: 31280934 Free article.
IgG4-Related Sclerosing Disease of the Temporal Bone: A Systematic Review.
Oochit KK, Wong YY, Mihuna A, Oliwa A, Kontorinis G. Oochit KK, et al. Otol Neurotol. 2022 Sep 1;43(8):856-863. doi: 10.1097/MAO.0000000000003614. Epub 2022 Aug 9. Otol Neurotol. 2022. PMID: 35941671
OBJECTIVE: IgG4-related disease (IgG4-RD) involving the temporal bone is an uncommon and underrecognized pathology often mistaken for malignancy. ...
OBJECTIVE: IgG4-related disease (IgG4-RD) involving the temporal bone is an uncommon and underrecognized pathology ofte …
FAPI-avid nonmalignant PET/CT findings: An expedited systematic review.
Bentestuen M, Al-Obaydi N, Zacho HD. Bentestuen M, et al. Semin Nucl Med. 2023 Sep;53(5):694-705. doi: 10.1053/j.semnuclmed.2023.02.001. Epub 2023 Feb 20. Semin Nucl Med. 2023. PMID: 36813670 Free article. Review.
For organs, diffuse or focal uptake was often seen in cases of inflammation, infection, fibrosis, and IgG4-related disease (n = 157, 7%). FAPI-avid inflammatory/reactive lymph nodes (n = 121, 5%) and tuberculosis lesions (n = 51, 2%) have been reported and co …
For organs, diffuse or focal uptake was often seen in cases of inflammation, infection, fibrosis, and IgG4-related disease …
33 results